NE HEALTH BUREAU NEW DELHI, NOV 26 The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate […]
IIL to invest Rs 75 cr to set up viral antigen manufacturing plant in Telangana; commits investment of Rs 150 cr towards fulfilment
NE BUSINESS BUREAU KARKAPATLA, NOV 25 Biologicals firm Indian Immunologicals Ltd (IIL) on Wednesday said it will invest […]
Alembic Pharma’s JV Aleor Dermaceuticals gets tentative nod from USFDA for testosterone gel
NE NEWS SERVICE NEW DELHI, NOV 25 Drug firm Alembic Pharmaceuticals on Wednesday said its joint venture Aleor […]
Glenmark’s Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19
NE HEALTH BUREAU AHMEDABAFD, NOV 25 The oral antiviral medication Favipiravir, which prevents the replication phase of the […]
COVID-19: Gujarat’s tally tops 2-lakh mark; Covaxin shots reach Sola Civil Hospital for phase-3 trials
NE NEWS SERVICE AHMEDABAD, NOV 24 Gujarat’s COVID-19 tally crossed the 2-lakh mark and rose to 2,00,409 with […]
Hester Biosciences Nepal launches live thermo-tolerant PPR vaccine
NE BUSINESS BUREAU AHMEDABAD, NOV 23 Hester Biosciences Nepal has developed and launched its Live Thermo-tolerant PPR (Peste […]
Over 100 scientists join hands with the UN to build public confidence in COVID-19 vaccines through Team Halo
NE HEALTH BUREAU AHMEDABAD, NOV 22 As the world eagerly awaits the rollout of COVID-19 vaccines, the United […]
Apollo Hospitals, TataMD partner to launch ‘TataMD CHECK’ test for COVID-19
NE HEALTH BUREAU CHENNAI, NOV 20 Healthcare major Apollo Hospitals Group and Tata Medical and Diagnostics Ltd (TataMD) […]
Zydus Cadila completes phase 2 clinical trial in COVID-19 patients with biological therapy PegiHep
NE NEWS SERVICE NEW DELHI, NOV 12 Drug firm Zydus Cadila on Thursday said it has successfully completed […]
Top domestic brokerages seem to be bullish on Gland Pharma IPO which hit the market on Monday
NE BUSINESS BUREAU HYDERABAD, NOV 12 The biggest pharma IPO by Gland Pharma got fully subscribed on the […]
